Novozymes A/S (VIE:NZYM)

Novozymes Statistics

Total Valuation

Novozymes has a market cap or net worth of EUR 27.90 billion. The enterprise value is 29.35 billion.

Market Cap	27.90B
Enterprise Value	29.35B

Important Dates

The next estimated earnings date is Thursday, August 21, 2025.

Earnings Date	Aug 21, 2025
Ex-Dividend Date	Apr 4, 2025

Share Statistics

Current Share Class	409.16M
Shares Outstanding	n/a
Shares Change (YoY)	-8.56%
Shares Change (QoQ)	+68.44%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	343.64M

Valuation Ratios

The trailing PE ratio is 60.85 and the forward PE ratio is 29.47.

PE Ratio	60.85
Forward PE	29.47
PS Ratio	6.88
PB Ratio	2.48
P/TBV Ratio	20.61
P/FCF Ratio	45.62
P/OCF Ratio	29.38
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 24.94, with an EV/FCF ratio of 47.99.

EV / Earnings	64.01
EV / Sales	7.24
EV / EBITDA	24.94
EV / EBIT	32.01
EV / FCF	47.99

Financial Position

The company has a current ratio of 1.66, with a Debt / Equity ratio of 0.15.

Current Ratio	1.66
Quick Ratio	1.03
Debt / Equity	0.15
Debt / EBITDA	1.44
Debt / FCF	2.78
Interest Coverage	11.41

Financial Efficiency

Return on equity (ROE) is 6.97% and return on invested capital (ROIC) is 7.25%.

Return on Equity (ROE)	6.97%
Return on Assets (ROA)	n/a
Return on Invested Capital (ROIC)	7.25%
Return on Capital Employed (ROCE)	6.64%
Revenue Per Employee	383,444
Profits Per Employee	43,328
Employee Count	10,582
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

In the past 12 months, Novozymes has paid 156.30 million in taxes.

Income Tax	156.30M
Effective Tax Rate	25.42%

Stock Price Statistics

The stock price has increased by +8.49% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	+8.49%
50-Day Moving Average	62.02
200-Day Moving Average	57.48
Relative Strength Index (RSI)	40.77
Average Volume (20 Days)	16

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Novozymes had revenue of EUR 4.06 billion and earned 458.50 million in profits. Earnings per share was 1.58.

Revenue	4.06B
Gross Profit	2.14B
Operating Income	921.70M
Pretax Income	614.80M
Net Income	458.50M
EBITDA	1.18B
EBIT	921.70M
Earnings Per Share (EPS)	1.58

Balance Sheet

The company has 249.50 million in cash and 1.70 billion in debt, giving a net cash position of -1.45 billion.

Cash & Cash Equivalents	249.50M
Total Debt	1.70B
Net Cash	-1.45B
Net Cash Per Share	n/a
Equity (Book Value)	11.23B
Book Value Per Share	24.09
Working Capital	775.70M

Cash Flow

In the last 12 months, operating cash flow was 949.80 million and capital expenditures -338.20 million, giving a free cash flow of 611.60 million.

Operating Cash Flow	949.80M
Capital Expenditures	-338.20M
Free Cash Flow	611.60M
FCF Per Share	n/a

Margins

Gross margin is 52.73%, with operating and profit margins of 22.72% and 11.30%.

Gross Margin	52.73%
Operating Margin	22.72%
Pretax Margin	15.15%
Profit Margin	11.30%
EBITDA Margin	29.12%
EBIT Margin	22.72%
FCF Margin	15.07%

Dividends & Yields

This stock pays an annual dividend of 0.83, which amounts to a dividend yield of 1.38%.

Dividend Per Share	0.83
Dividend Yield	1.38%
Dividend Growth (YoY)	-0.08%
Years of Dividend Growth	n/a
Payout Ratio	54.46%
Buyback Yield	8.56%
Shareholder Yield	9.94%
Earnings Yield	1.64%
FCF Yield	2.19%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Novozymes has an Altman Z-Score of 5.71 and a Piotroski F-Score of 3.

Altman Z-Score	5.71
Piotroski F-Score	3